Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02317991
Title Study of Nab-Paclitaxel and Ramucirumab as Second-line Treatment for Patients With Metastatic Gastroesophageal Cancer
Recruitment Completed
Gender
Phase Phase II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Nab-paclitaxel + Ramucirumab

Age Groups:
Covered Countries USA


No variant requirements are available.